Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.6.0.2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2013 $ (36,373) $ 27,324 $ 3 $ 1,656 $ 0 $ (38,032)
Balance (in shares) at Dec. 31, 2013   25,924 3,016      
Issuance of common stock upon exercise of stock options 2   $ 0 2 0 0
Issuance of common stock upon exercise of stock options (in shares)     13      
Fair value of warrant liability transferred to equity upon net exercise 282   $ 0 282 0 0
Fair value of warrant liability transferred to equity upon net exercise (in shares)   767        
Conversion of preferred stock 27,324 $ (27,324) $ 4 27,320 0 0
Conversion of preferred stock (in shares)   (26,691) 3,813      
Balance at Jan. 14, 2014 (8,765) $ 0 $ 7 29,260 0 (38,032)
Balance (in shares) at Jan. 14, 2014   0 6,842      
Balance at Dec. 31, 2013 (36,373) $ 27,324 $ 3 1,656 0 (38,032)
Balance (in shares) at Dec. 31, 2013   25,924 3,016      
Net loss (33,769)          
Foreign currency translation adjustments 0          
Balance at Dec. 31, 2014 22,800 $ 0 $ 15 94,586 0 (71,801)
Balance (in shares) at Dec. 31, 2014   0 14,517      
Balance at Jan. 14, 2014 (8,765) $ 0 $ 7 29,260 0 (38,032)
Balance (in shares) at Jan. 14, 2014   0 6,842      
PPO shares issued for cash 25,300 $ 0 $ 4 25,296 0 0
PPO shares issued for cash (in shares)     3,614      
PPO shares issued upon conversion of 2013 Bridge Notes 5,082 0 $ 1 5,081 0 0
PPO shares issued upon conversion of 2013 Bridge Notes (in shares)     714      
Shares issued to consultant in PPO 0   $ 0 0 0 0
Shares issued to consultant in PPO (in shares)     36      
Fair value of warrant obligation transferred to equity 96 0 $ 0 96 0 0
Unamortized debt discounts transferred to equity (947) 0 0 (947) 0 0
Offering costs of PPO shares (3,339) 0 0 (3,339) 0 0
Issuance of common stock warrants at fair value (10,614) 0 0 (10,614) 0 0
Balance at Jan. 16, 2014 6,813 $ 0 $ 12 44,833 0 (38,032)
Balance (in shares) at Jan. 16, 2014   0 11,206      
Issuance of common stock upon exercise of warrants 21,412 $ 0 $ 3 21,409 0 0
Issuance of common stock upon exercise of warrants (in shares)     3,269      
Fair value of warrant anti-dilution feature transferred to equity 27,099 0 $ 0 27,099 0 0
Issuance of common stock upon exercise of stock options 102 0 $ 0 102 0 0
Issuance of common stock upon exercise of stock options (in shares)     42      
Stock-based compensation expense 1,143 0 $ 0 1,143 0 0
Net loss (33,769) 0 0 0 0 (33,769)
Balance at Dec. 31, 2014 22,800 $ 0 $ 15 94,586 0 (71,801)
Balance (in shares) at Dec. 31, 2014   0 14,517      
Issuance of common stock/preferred stock 14,218 $ 0 $ 0 14,218 0 0
Issuance of common stock/preferred stock (in shares)   15 0      
Allocation of proceeds from Series A preferred stock to warrant liability (11,700) $ 0 $ 0 (11,700) 0 0
Beneficial conversion feature on Series A preferred stock 3,300 0 0 3,300 0 0
Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount 1,356 $ 0 $ 0 1,356 0 0
Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount (in shares)   (2) 246      
Deemed dividend on Series A convertible preferred stock (4,655) $ 0 $ 0 (4,655) 0 0
Issuance of common stock for assets acquired from Equipois 1,071 0 $ 0 1,071 0 0
Issuance of common stock for assets acquired from Equipois (in shares)     112      
Issuance of common stock upon exercise of warrants 53 0 $ 0 53 0 0
Issuance of common stock upon exercise of warrants (in shares)     7      
Issuance of common stock upon exercise of stock options 225 0 $ 0 225 0 0
Issuance of common stock upon exercise of stock options (in shares)     145      
Stock-based compensation expense 1,731 0 $ 0 1,731 0 0
Net loss (19,590) 0 0 0 0 (19,590)
Foreign currency translation adjustments (1) 0 0 0 (1) 0
Balance at Dec. 31, 2015 8,808 $ 0 $ 15 100,185 (1) (91,391)
Balance (in shares) at Dec. 31, 2015   13 15,027      
Shares issued as a result of rounding due to reverse-stock split 0 $ 0 $ 0 0 0 0
Shares issued as a result of rounding due to reverse-stock split (in share)     8      
Issuance of common stock/preferred stock 14,694 $ 0 $ 4 14,690 0 0
Issuance of common stock/preferred stock (in shares)   0 4,017      
Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount 10,345 $ 0 $ 3 10,342 0 0
Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount (in shares)   (13) 2,310      
Deemed dividend on Series A convertible preferred stock (10,345) $ 0 $ 0 (10,345) 0 0
Issuance of common stock upon exercise of warrants 3,188 0 $ 0 3,188 0 0
Issuance of common stock upon exercise of warrants (in shares)     488      
Issuance of common stock upon exercise of stock options 110 0 $ 0 110 0 0
Issuance of common stock upon exercise of stock options (in shares)     44      
Stock-based compensation expense 3,121 0 $ 0 3,121 0 0
Net loss (23,470) 0 0 0 0 (23,470)
Foreign currency translation adjustments 80 0 0 0 80 0
Balance at Dec. 31, 2016 $ 6,531 $ 0 $ 22 $ 121,291 $ 79 $ (114,861)
Balance (in shares) at Dec. 31, 2016   0 21,894